Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.
Scorpius Biomanufacturing has raised $1.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2024.
Scorpius Biomanufacturing is headquartered in San Antonio, United States.
Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.
Scorpius Biomanufacturing is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scorpius Biomanufacturing — Funding & Investors." VCBacked, March 8, 2024, https://www.vcbacked.co/company/scorpius-biomanufacturing. Accessed August 14, 2026.
VCBacked. (2024). Scorpius Biomanufacturing — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/scorpius-biomanufacturing
{{cite web |title=Scorpius Biomanufacturing — Funding & Investors |url=https://www.vcbacked.co/company/scorpius-biomanufacturing |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated